CAS RN: 1464137-25-4
(R)-8-((4-(Trifluoromethyl)phenyl)sulfonyl)hexahydropyrazino[2,1-c][1,4]oxazin-4(3H)-one
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1464137-25-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
1464137-25-4 / (9aR)-8-[4-(trifluoromethyl)phenyl]sulfonyl-6,7,9,9a-tetrahydro-1H-pyrazino[2,1-c][1,4]oxazin-4-one
Standard CAS: 1464137-25-4
Multi CAS: No
Basic Information
copy
CAS
1464137-25-4 copy
Multi CAS
No copy
Molecular Formula
C14H15F3N2O4S copy
Molecular Weight
364.340000 copy
Exact Mass
364.070463 copy
SMILES
C1CN2[C@H](CN1S(=O)(=O)C3=CC=C(C=C3)C(F)(F)F)COCC2=O copy
InChI
InChI=1S/C14H15F3N2O4S/c15-14(16,17)10-1-3-12(4-2-10)24(21,22)18-5-6-19-11(7-18)8-23-9-13(19)20/h1-4,11H,5-9H2/t11-/m1/s1 copy
InChIKey
QXBCCNAVBIVTBX-LLVKDONJSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
24 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.5 copy
Rotatable bonds
2 copy
H-bond acceptors
4 copy
Molar refractivity
76.52 copy
TPSA
66.92 copy
LogP / Solubility
WLOGP
0.94 copy
MLOGP
0.84 copy
XLogP3
0.9 copy
Consensus LogP
0.89 copy
Log S (ESOL)
-2.74 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.22 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.05 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.28 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy